Laypeople rated AI-generated medical responses as more satisfying than clinician responses, especially in cardiology, but empathy and quality shined in endocrinology responses.
European Commission greenlights Mirati’s Krazati in KRAS-mutated NSCLC – Pharmaceutical Technology
Share this article Krazati is forecast to generate $1.24bn in sales in 2029, according to GlobalData. Credit: gorodenkoff via Getty Images. Mirati Therapeutics has received